Ethiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Department of Microbial, Cellular and Molecular Biology, College of Natural Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Malar J. 2019 Aug 27;18(1):292. doi: 10.1186/s12936-019-2927-3.
Malaria remains a very important public health problem in Ethiopia. Currently, only Plasmodium falciparum and Plasmodium vivax are considered in the malaria diagnostic and treatment policies. However, the existence and prevalence of Plasmodium ovale spp. and Plasmodium malariae in Ethiopia have not been extensively investigated. The objective of this study was to use a multiplex IgG antibody detection assay to evaluate evidence for exposure to any of these four human malaria parasites among asymptomatic individuals.
Dried blood spots (DBS) were collected from 180 healthy study participants during a 2016 onchocerciasis survey in the Jimma Zone, southwest Ethiopia. IgG antibody reactivity was detected using a multiplex bead assay for seven Plasmodium antigens: P. falciparum circumsporozoite protein (CSP), P. falciparum apical membrane antigen-1 (AMA1), P. falciparum liver stage antigen-1 (LSA1), and homologs of the merozoite surface protein-1 (MSP1)-19kD antigens that are specific for P. falciparum, P. vivax, P. ovale spp. and P. malariae.
One hundred six participants (59%) were IgG seropositive for at least one of the Plasmodium antigens tested. The most frequent responses were against P. falciparum AMA1 (59, 33%) and P. vivax (55, 28%). However, IgG antibodies against P. ovale spp. and P. malariae were detected in 19 (11%) and 13 (7%) of the participants, respectively, providing serological evidence that P. malariae and P. ovale spp., which are rarely reported, may also be endemic in Jimma.
The findings highlight the informative value of multiplex serology and the need to confirm whether P. malariae and P. ovale spp. are aetiologies of malaria in Ethiopia, which is critical for proper diagnosis and treatment.
疟疾在埃塞俄比亚仍然是一个非常重要的公共卫生问题。目前,疟疾的诊断和治疗政策仅考虑到恶性疟原虫和间日疟原虫。然而,卵形疟原虫和恶性疟原虫在埃塞俄比亚的存在和流行情况尚未得到广泛调查。本研究旨在使用多重 IgG 抗体检测法评估无症状个体中是否存在这四种人类疟原虫。
在 2016 年埃塞俄比亚西南部吉马地区的盘尾丝虫病调查期间,采集了 180 名健康研究参与者的干血斑(DBS)。使用针对 7 种疟原虫抗原的多重珠状检测法检测 IgG 抗体反应性:恶性疟原虫环子孢子蛋白(CSP)、恶性疟原虫顶膜抗原-1(AMA1)、恶性疟原虫肝期抗原-1(LSA1)以及恶性疟原虫、间日疟原虫、卵形疟原虫和三日疟原虫特异性的裂殖体表面蛋白-1(MSP1)-19kD 抗原的同源物。
106 名参与者(59%)对至少一种检测的疟原虫抗原呈 IgG 血清阳性反应。最常见的反应是针对恶性疟原虫 AMA1(59,33%)和间日疟原虫(55,28%)。然而,19 名(11%)和 13 名(7%)参与者中分别检测到针对卵形疟原虫和三日疟原虫的 IgG 抗体,这提供了血清学证据表明,罕见报道的卵形疟原虫和三日疟原虫也可能在吉马流行。
研究结果强调了多重血清学的信息价值,需要确认卵形疟原虫和三日疟原虫是否是埃塞俄比亚疟疾的病因,这对于正确诊断和治疗至关重要。